Skip to main content
icon-treatment_guides_article
Treatment guidelines

Bisphosphonates

Key points

  • Bisphosphonates (BP) maintain bone mass and stability and are used in treatment of bone diseases such as osteoporosis
  • BP therapy in osteoporosis patients is not a contra-indication for implant treatment
  • BP medication for bone cancers like multiple myeloma constitute a contra-indication for implant treatment

Clinical topics

Systemic factors
Patient assessment

Related articles

icon-treatment_guides_article

Treatment guidelines

Edentulous

0572_Thumb_Bronj.png

BRONJ / ARONJ

A critical side effect in the oro-maxillo-facial region observed in patients undergoing administration over a long period of time and especially intravenously, bisphosphonate therapy may predispose to ‘bisphosphonate-related osteonecrosis of the...

Systemic factors
Patient assessment
icon-treatment_guides_article

Treatment guidelines

Edentulous

Osteoporosis.png

Osteoporosis

Osteoporosis is a frequent disease affecting predominantly postmenopausal women. The prevalence is 7% in women aged 55 and raises to 19% in women aged 80. Osteoporosis is diagnosed by a decreased radiologic bone density (DXA-score). Primary osteoporosis is more...

Systemic factors
Patient assessment
icon-treatment_guides_article

Treatment guidelines

It is helpful if a clinician is situated so that his/her eyes are at the level of the patient's eyes. For example, if the patient is seated, the clinician should also be seated. It is beneficial if the interview between clinician and...

Systemic factors
Patient assessment

Questions

Log in or register to post questions and answers.